group_name,group_level,strata_name,strata_level,variable,variable_level,variable_type,estimate_type,estimate,cdm_name
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number subjects,NA,NA,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number records,NA,NA,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,median,59,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,q75,69,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,median,274,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,q25,122,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,q75,436,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,median,1001,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,q25,560,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,q75,1486,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,median,2021-11-01,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q25,2021-04-14,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q75,2022-04-04,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,median,2021-05-06,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q25,2020-12-04,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q75,2021-10-22,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,4376,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,28.7781139024069,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,count,7591,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,%,49.9210837827173,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,count,5314,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,%,34.9467315533342,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,count,3392,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,%,22.3069840852295,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,11095,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,72.9646192292516,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,count,2075,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,%,13.6459292384585,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,count,4691,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,%,30.8496646060765,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,count,2224,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,%,14.6258056030514,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,count,3154,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,%,20.7418124424569,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,count,2443,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,%,16.0660265684598,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,count,1496,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,%,9.83822175457057,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,count,1496,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,%,9.83822175457057,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,count,1540,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,%,10.1275812179403,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,count,3826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,%,25.1611206102854,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,count,213,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,%,1.40076285676707,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,count,3853,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,%,25.3386820991714,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,count,2899,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,%,19.0648428252006,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,count,2952,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,%,19.4133894515323,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,count,4438,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,%,29.1858476917006,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,3832,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,25.2005787189267,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2263,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,%,14.88228330922,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,count,4415,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,%,29.0345916085756,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,count,970,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,%,6.37906089701434,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,%,0.144679731684861,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,944,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.20807575956859,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,count,7660,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,%,50.3748520320926,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,count,2964,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,%,19.4923056688149,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,count,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,%,0.657635144022097,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,count,699,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.59686965671446,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,count,4802,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,%,31.5796396159411,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,%,0.00657635144022097,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,count,2536,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,%,16.6776272524004,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,count,281,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,%,1.84795475470209,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,count,4319,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,%,28.4032618703143,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,count,1853,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,%,12.1859792187294,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,count,1175,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,%,7.72721294225963,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,count,4420,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,%,29.0674733657767,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,count,503,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,%,3.30790477443115,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,count,7299,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,%,48.0007891621728,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,count,384,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,%,2.52531895304485,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,count,509,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,%,3.34736288307247,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,count,511,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,%,3.36051558595291,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,count,1938,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,%,12.7449690911482,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,count,5344,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,%,35.1440220965408,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,count,6232,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,%,40.9838221754571,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,count,1181,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,%,7.76667105090096,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,covid,categorical,count,69,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,covid,categorical,%,0.453768249375247,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,malaria,categorical,%,0.00657635144022097,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,multiple,categorical,count,55,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,multiple,categorical,%,0.361699329212153,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,none,categorical,count,7830,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,none,categorical,%,51.4928317769302,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,count,7251,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,%,47.6851242930422,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Female,categorical,count,10590,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Female,categorical,%,69.64356175194,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Male,categorical,count,4616,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Male,categorical,%,30.35643824806,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number subjects,NA,NA,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number records,NA,NA,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,median,59,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,q25,48,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,q75,68,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,median,793,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,q25,293,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,q75,1092,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,median,730,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,q75,874,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,median,2019-09-26,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,q25,2019-05-05,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,q75,2020-03-10,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,median,2019-03-13,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,q25,2019-01-01,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,q75,2019-08-15,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,5676,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,30.2397442727757,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,count,10605,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,%,56.4997336174747,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,count,5372,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,%,28.6201385189132,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,count,3814,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,%,20.3196590303676,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,13890,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,74.0010655301012,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,count,2246,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,%,11.9659030367608,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,count,4249,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,%,22.6371870005328,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,count,2458,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,%,13.0953649440597,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,count,3860,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,%,20.5647309536494,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,count,2779,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,%,14.8055407565264,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,count,1449,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,%,7.71976558337773,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,count,1449,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,%,7.71976558337773,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,count,1515,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,%,8.0713905167821,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,count,1129,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,%,6.01491742141716,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,count,245,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,%,1.30527437400107,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,count,3671,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,%,19.5578050079915,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,count,3184,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,%,16.9632392115077,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,count,3508,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,%,18.6893979754928,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5287,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.1672882258924,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,4705,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,25.0665956313266,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2556,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.6174746936601,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,count,4643,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,%,24.7362812999467,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,count,924,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,%,4.92274906766116,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,%,0.138518913159297,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,1108,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,5.90303676078849,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,count,9293,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,%,49.5098561534363,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,count,3381,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,%,18.0127863612147,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,count,86,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,%,0.458177943526905,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,count,813,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.33137986148109,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,count,5688,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,%,30.3036760788492,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,%,0.0159829515183804,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,count,2695,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,%,14.3580181140117,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,count,297,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,%,1.58231220031966,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,count,5915,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,%,31.51305274374,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,count,2151,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,%,11.4597762386787,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,count,1284,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,%,6.84070324986681,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,count,4899,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,%,26.1001598295152,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,count,473,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,%,2.51997868939798,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,count,10024,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,%,53.404368673415,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,count,379,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,%,2.01917954182206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,count,521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,%,2.77570591369206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,0 to 19,categorical,count,663,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,0 to 19,categorical,%,3.53223228556207,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,20 to 39,categorical,count,2077,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,20 to 39,categorical,%,11.0655301012254,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,40 to 59,categorical,count,7065,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,40 to 59,categorical,%,37.6398508257858,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,60 to 79,categorical,count,7471,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,60 to 79,categorical,%,39.8028769312733,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,80 to 150,categorical,count,1494,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,80 to 150,categorical,%,7.95950985615344,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,multiple,categorical,%,0.0159829515183804,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,none,categorical,count,8741,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,none,categorical,%,46.5689930740543,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,count,10026,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,%,53.4150239744273,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Female,categorical,count,12892,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Female,categorical,%,68.6840703249867,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Male,categorical,count,5878,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Male,categorical,%,31.3159296750133,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,before_pandemic,categorical,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,before_pandemic,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number subjects,NA,NA,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number records,NA,NA,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,median,58,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q75,67,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,median,680,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q25,293,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q75,752,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,median,1092,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q25,514,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q75,1181,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,median,2020-07-23,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q25,2020-05-17,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q75,2020-12-25,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,median,2020-03-27,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q25,2020-02-28,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q75,2020-05-05,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,1021,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,28.9974439079807,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,count,1915,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,%,54.3879579664868,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,count,1036,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,%,29.4234592445328,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,count,729,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,%,20.7043453564328,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,2606,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,74.0130644703209,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,count,381,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,%,10.8207895484237,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,count,913,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,%,25.9301334848055,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,count,485,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,%,13.7744958818517,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,count,678,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,%,19.2558932121556,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,count,556,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,%,15.7909684748651,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,count,283,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,%,8.03748934961659,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,count,283,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,%,8.03748934961659,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,count,289,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,%,8.20789548423743,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,count,310,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,%,8.80431695541039,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,count,45,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,%,1.27804600965635,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,count,790,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,%,22.4368077250781,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,count,643,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,%,18.2618574268674,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,count,655,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,%,18.6026696961091,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,1005,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.5430275489918,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,863,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,24.5100823629651,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,482,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.6892928145413,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,count,989,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,%,28.0886111900028,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,count,170,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,%,4.82817381425731,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,%,0.0568020448736154,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,263,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.46946890088043,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,count,1753,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,%,49.7869923317239,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,count,628,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,%,17.8358420903152,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,%,0.852030673104232,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,148,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.20335132064754,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,count,1006,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,547,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,15.5353592729338,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,count,52,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,%,1.476853166714,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,count,1086,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,%,30.8435103663732,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,count,371,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,%,10.5367793240557,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,count,241,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,%,6.84464640727066,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,count,960,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,%,27.2649815393354,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,count,82,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,%,2.32888383981823,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,1843,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,52.3430843510366,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,count,68,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,%,1.93126952570293,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,count,98,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,%,2.78330019880716,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,count,105,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,%,2.98210735586481,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,count,408,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,%,11.5876171542176,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,count,1387,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,%,39.3922181198523,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,count,1378,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,%,39.136608917921,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,count,243,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,%,6.90144845214428,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,%,0.0284010224368077,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,%,0.0284010224368077,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,none,categorical,count,1676,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,none,categorical,%,47.6001136040897,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,count,1843,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,%,52.3430843510366,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,count,2409,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,%,68.4180630502698,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,count,1112,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,%,31.5819369497302,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number subjects,NA,NA,count,70,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number records,NA,NA,count,70,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age,NA,numeric,median,53,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age,NA,numeric,q25,34.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age,NA,numeric,q75,62.75,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,future_observation,NA,numeric,median,143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,future_observation,NA,numeric,q25,72.25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,future_observation,NA,numeric,q75,397,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,prior_history,NA,numeric,median,826,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,prior_history,NA,numeric,q25,500.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,prior_history,NA,numeric,q75,1486.25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_end_date,NA,date,median,2022-01-14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_end_date,NA,date,q25,2021-08-08,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_end_date,NA,date,q75,2022-04-11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_start_date,NA,date,median,2021-10-16,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_start_date,NA,date,q25,2021-02-17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_start_date,NA,date,q75,2022-01-10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,21.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,count,48,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,%,68.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antidepressants_m365_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antidepressants_m365_to_0,NA,binary,%,41.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antiepileptics_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antiepileptics_m365_to_0,NA,binary,%,21.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,52,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,74.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,count,70,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antithrombotics_m365_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antithrombotics_m365_to_0,NA,binary,%,27.1428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,anxiety_minf_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,anxiety_minf_to_0,NA,binary,%,37.1428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,asthma_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,asthma_minf_to_0,NA,binary,%,17.1428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,%,15.7142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,%,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,%,7.14285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,%,7.14285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,copd_minf_to_0,NA,binary,%,5.71428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,covid_minf_to_0,NA,binary,count,70,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,covid_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,dementia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,dementia_minf_to_0,NA,binary,%,1.42857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,depressive_disorder_minf_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,depressive_disorder_minf_to_0,NA,binary,%,25.7142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,diabetes_minf_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,diabetes_minf_to_0,NA,binary,%,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,diuretics_m365_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,diuretics_m365_to_0,NA,binary,%,22.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,37.1428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,12.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,gerd_minf_to_0,NA,binary,count,25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,gerd_minf_to_0,NA,binary,%,35.7142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,heart_failure_minf_to_0,NA,binary,%,5.71428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,5.71428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hypertension_minf_to_0,NA,binary,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hypertension_minf_to_0,NA,binary,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hypothyroidism_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hypothyroidism_minf_to_0,NA,binary,%,12.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,immunosupressants_m365_to_0,NA,binary,count,70,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,8.57142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,%,25.7142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,12.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,%,1.42857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,opioids_m365_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,opioids_m365_to_0,NA,binary,%,34.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,osteoporosis_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,osteoporosis_minf_to_0,NA,binary,%,8.57142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,pneumonia_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,pneumonia_minf_to_0,NA,binary,%,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,psycholeptics_m365_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,psycholeptics_m365_to_0,NA,binary,%,37.1428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,psychostimulants_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,psychostimulants_m365_to_0,NA,binary,%,7.14285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,stroke_minf_to_0,NA,binary,%,1.42857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,%,7.14285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,0 to 19,categorical,%,5.71428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,20 to 39,categorical,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,20 to 39,categorical,%,21.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,40 to 59,categorical,count,27,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,40 to 59,categorical,%,38.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,60 to 79,categorical,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,60 to 79,categorical,%,30,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,80 to 150,categorical,%,4.28571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,covid,categorical,count,70,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,sex,Female,categorical,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,sex,Female,categorical,%,65.7142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,sex,Male,categorical,count,24,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,sex,Male,categorical,%,34.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,after_fda_retraction,categorical,count,69,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,after_fda_retraction,categorical,%,98.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,during_hcq_use_for_covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,during_hcq_use_for_covid,categorical,%,1.42857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number subjects,NA,NA,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number records,NA,NA,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,future_observation,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,future_observation,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,future_observation,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,prior_history,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,prior_history,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,prior_history,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_end_date,NA,date,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_end_date,NA,date,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_end_date,NA,date,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_start_date,NA,date,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_start_date,NA,date,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_start_date,NA,date,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antibacterials_systemic_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antibacterials_systemic_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antidepressants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antidepressants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antiepileptics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antiepileptics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antineoplastic_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antineoplastic_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antithrombotics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antithrombotics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,anxiety_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,anxiety_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,asthma_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,asthma_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,beta_blocking_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,beta_blocking_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,calicum_channel_blockers_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,calicum_channel_blockers_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,chronic_kidney_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,chronic_kidney_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,chronic_liver_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,chronic_liver_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,copd_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,copd_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,covid_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,covid_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,dementia_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,dementia_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,depressive_disorder_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,depressive_disorder_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,diabetes_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,diabetes_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,diuretics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,diuretics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_acid_related_disorder_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_acid_related_disorder_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_used_in_diabetes_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_used_in_diabetes_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,gerd_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,gerd_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,heart_failure_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,heart_failure_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hiv_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hiv_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hypertension_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hypertension_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hypothyroidism_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hypothyroidism_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,immunosupressants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,immunosupressants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,infertility_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,infertility_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,inflammatory_bowel_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,inflammatory_bowel_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,lipid_modifying_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,lipid_modifying_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,malaria_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,malaria_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,malignant_neoplastic_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,malignant_neoplastic_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,myocardial_infarction_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,myocardial_infarction_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number_visits,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number_visits,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number_visits,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,opioids_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,opioids_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,osteoporosis_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,osteoporosis_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,pneumonia_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,pneumonia_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,psycholeptics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,psycholeptics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,psychostimulants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,psychostimulants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,rheumatoid_arthritis_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,rheumatoid_arthritis_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,stroke_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,stroke_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,venous_thromboembolism_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,venous_thromboembolism_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,40 to 59,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,40 to 59,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,60 to 79,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,60 to 79,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,0 to 19,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,0 to 19,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,20 to 39,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,20 to 39,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,80 to 150,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,80 to 150,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,malaria,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,malaria,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,rheumatoid_arthritis,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,rheumatoid_arthritis,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,none,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,none,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,covid,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,covid,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,multiple,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,multiple,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,sex,Female,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,sex,Female,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,sex,Male,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,sex,Male,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,after_fda_retraction,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,after_fda_retraction,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,before_pandemic,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,before_pandemic,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,during_hcq_use_for_covid,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,during_hcq_use_for_covid,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number subjects,NA,NA,count,59,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number records,NA,NA,count,59,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,median,58,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,q25,50.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,q75,66.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,median,153.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,q25,55.25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,q75,392.75,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,median,746,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,q25,442.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,q75,1441,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,median,2022-03-15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,q25,2021-05-01,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,q75,2022-04-26,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,median,2021-09-20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,q25,2020-12-20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,q75,2022-02-03,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,44.0677966101695,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,count,42,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,%,71.1864406779661,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antidepressants_m365_to_0,NA,binary,count,25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antidepressants_m365_to_0,NA,binary,%,42.3728813559322,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiepileptics_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiepileptics_m365_to_0,NA,binary,%,30.5084745762712,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,55,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,93.2203389830509,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,count,59,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antithrombotics_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antithrombotics_m365_to_0,NA,binary,%,10.1694915254237,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,anxiety_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,anxiety_minf_to_0,NA,binary,%,27.1186440677966,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,asthma_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,asthma_minf_to_0,NA,binary,%,16.9491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,%,27.1186440677966,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,%,25.4237288135593,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,%,16.9491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,%,16.9491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,copd_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,copd_minf_to_0,NA,binary,%,13.5593220338983,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,covid_minf_to_0,NA,binary,count,56,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,covid_minf_to_0,NA,binary,%,94.9152542372881,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,dementia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,dementia_minf_to_0,NA,binary,%,5.08474576271186,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,%,25.4237288135593,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diabetes_minf_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diabetes_minf_to_0,NA,binary,%,33.8983050847458,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diuretics_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diuretics_m365_to_0,NA,binary,%,28.8135593220339,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,%,45.7627118644068,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,40.6779661016949,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,%,28.8135593220339,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,gerd_minf_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,gerd_minf_to_0,NA,binary,%,44.0677966101695,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,heart_failure_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,heart_failure_minf_to_0,NA,binary,%,16.9491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,1.69491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypertension_minf_to_0,NA,binary,count,36,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypertension_minf_to_0,NA,binary,%,61.0169491525424,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,%,18.6440677966102,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,immunosupressants_m365_to_0,NA,binary,count,59,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,%,37.2881355932203,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malaria_minf_to_0,NA,binary,%,5.08474576271186,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,%,6.77966101694915,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,opioids_m365_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,opioids_m365_to_0,NA,binary,%,33.8983050847458,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,osteoporosis_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,osteoporosis_minf_to_0,NA,binary,%,15.2542372881356,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,pneumonia_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,pneumonia_minf_to_0,NA,binary,%,16.9491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psycholeptics_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psycholeptics_m365_to_0,NA,binary,%,25.4237288135593,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,count,59,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,stroke_minf_to_0,NA,binary,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,20 to 39,categorical,%,1.69491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,40 to 59,categorical,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,40 to 59,categorical,%,50.8474576271186,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,60 to 79,categorical,count,25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,60 to 79,categorical,%,42.3728813559322,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,80 to 150,categorical,%,5.08474576271186,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,multiple,categorical,count,59,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,multiple,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Female,categorical,count,49,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Female,categorical,%,83.0508474576271,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Male,categorical,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Male,categorical,%,16.9491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,after_fda_retraction,categorical,count,55,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,after_fda_retraction,categorical,%,93.2203389830509,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,before_pandemic,categorical,%,5.08474576271186,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,during_hcq_use_for_covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,during_hcq_use_for_covid,categorical,%,1.69491525423729,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number subjects,NA,NA,count,18247,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number records,NA,NA,count,18247,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,median,55,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,q25,41,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,q75,65,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,median,399,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,q25,175,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,q75,762,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,median,807,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,q25,652.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,q75,1143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,median,2020-08-25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,q25,2019-09-28,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,q75,2021-09-15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,median,2020-02-26,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,q25,2019-04-18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,q75,2021-03-17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,4781,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,26.2015673809393,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,count,9749,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,%,53.427960760673,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antidepressants_m365_to_0,NA,binary,count,5508,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antidepressants_m365_to_0,NA,binary,%,30.1857839644873,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiepileptics_m365_to_0,NA,binary,count,3564,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiepileptics_m365_to_0,NA,binary,%,19.5319778593741,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,12609,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,69.1017701539979,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,count,18247,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antithrombotics_m365_to_0,NA,binary,count,2206,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antithrombotics_m365_to_0,NA,binary,%,12.0896585740122,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,anxiety_minf_to_0,NA,binary,count,4995,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,anxiety_minf_to_0,NA,binary,%,27.3743629089713,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,asthma_minf_to_0,NA,binary,count,2458,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,asthma_minf_to_0,NA,binary,%,13.4707075135639,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,count,3411,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,%,18.6934838603606,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,count,2541,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,%,13.9255768071464,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,count,1413,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,%,7.74373869677207,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,count,1413,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,%,7.74373869677207,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,copd_minf_to_0,NA,binary,count,1243,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,copd_minf_to_0,NA,binary,%,6.81207869786814,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,covid_minf_to_0,NA,binary,count,2762,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,covid_minf_to_0,NA,binary,%,15.1367348057215,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,dementia_minf_to_0,NA,binary,count,163,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,dementia_minf_to_0,NA,binary,%,0.893297528360826,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,depressive_disorder_minf_to_0,NA,binary,count,4003,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,depressive_disorder_minf_to_0,NA,binary,%,21.9378527977202,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diabetes_minf_to_0,NA,binary,count,3086,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diabetes_minf_to_0,NA,binary,%,16.9123691565737,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diuretics_m365_to_0,NA,binary,count,3103,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diuretics_m365_to_0,NA,binary,%,17.0055351564641,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5021,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,%,27.5168520852743,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,4257,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,23.3298624431413,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2557,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,%,14.013262454102,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,gerd_minf_to_0,NA,binary,count,4536,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,gerd_minf_to_0,NA,binary,%,24.8588809119307,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,heart_failure_minf_to_0,NA,binary,count,850,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,heart_failure_minf_to_0,NA,binary,%,4.65829999451965,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hiv_minf_to_0,NA,binary,count,32,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hiv_minf_to_0,NA,binary,%,0.175371293911328,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,1311,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.18474269742971,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypertension_minf_to_0,NA,binary,count,8196,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypertension_minf_to_0,NA,binary,%,44.9169726530389,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypothyroidism_minf_to_0,NA,binary,count,2953,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypothyroidism_minf_to_0,NA,binary,%,16.1834822162547,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,immunosupressants_m365_to_0,NA,binary,count,18247,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,infertility_minf_to_0,NA,binary,count,194,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,infertility_minf_to_0,NA,binary,%,1.06318846933743,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,count,1313,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,%,7.19570340329917,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,count,4952,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,%,27.138707732778,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,count,3105,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,%,17.0164958623335,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,myocardial_infarction_minf_to_0,NA,binary,count,249,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,myocardial_infarction_minf_to_0,NA,binary,%,1.36460788074752,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,opioids_m365_to_0,NA,binary,count,5240,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,opioids_m365_to_0,NA,binary,%,28.7170493779799,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,osteoporosis_minf_to_0,NA,binary,count,1192,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,osteoporosis_minf_to_0,NA,binary,%,6.53258069819696,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,pneumonia_minf_to_0,NA,binary,count,1157,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,pneumonia_minf_to_0,NA,binary,%,6.34076834548145,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psycholeptics_m365_to_0,NA,binary,count,5291,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psycholeptics_m365_to_0,NA,binary,%,28.9965473776511,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psychostimulants_m365_to_0,NA,binary,count,631,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psychostimulants_m365_to_0,NA,binary,%,3.458102701814,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,stroke_minf_to_0,NA,binary,count,326,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,stroke_minf_to_0,NA,binary,%,1.78659505672165,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,count,518,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,%,2.83882282018962,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,0 to 19,categorical,count,1068,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,0 to 19,categorical,%,5.85301693429057,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,20 to 39,categorical,count,3178,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,20 to 39,categorical,%,17.4165616265688,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,40 to 59,categorical,count,6949,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,40 to 59,categorical,%,38.0829725434318,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,60 to 79,categorical,count,6048,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,60 to 79,categorical,%,33.145174549241,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,80 to 150,categorical,count,1004,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,80 to 150,categorical,%,5.50227434646791,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,none,categorical,count,18247,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,none,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Female,categorical,count,11529,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Female,categorical,%,63.1829889844906,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Male,categorical,count,6718,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Male,categorical,%,36.8170110155094,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,after_fda_retraction,categorical,count,7830,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,after_fda_retraction,categorical,%,42.911163478928,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,before_pandemic,categorical,count,8741,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,before_pandemic,categorical,%,47.9037650024662,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,during_hcq_use_for_covid,categorical,count,1676,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,during_hcq_use_for_covid,categorical,%,9.1850715186058,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number subjects,NA,NA,count,19120,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number records,NA,NA,count,19120,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,median,62,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,q25,53,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,q75,71,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,median,451,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q25,196,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q75,833.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,median,737,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q25,624,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q75,1071,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,median,2020-08-24,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q25,2019-09-20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q75,2021-10-15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,median,2020-01-09,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q25,2019-02-03,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q75,2021-01-29,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,6250,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,32.6882845188285,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,count,10271,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,%,53.7186192468619,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,count,6159,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,%,32.2123430962343,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,count,4338,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,%,22.6882845188285,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,14874,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,77.7928870292887,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,count,19120,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,count,2471,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,%,12.923640167364,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,count,4815,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,%,25.1830543933054,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,count,2686,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,%,14.0481171548117,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,count,4253,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,%,22.2437238493724,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,count,3214,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,%,16.8096234309623,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,count,1800,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,%,9.41422594142259,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,count,1800,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,%,9.41422594142259,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,count,2089,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,%,10.9257322175732,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,count,2377,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,%,12.4320083682008,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,count,336,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,%,1.75732217573222,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,count,4278,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,%,22.3744769874477,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,count,3606,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,%,18.8598326359833,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,count,3979,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,%,20.8106694560669,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5656,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,%,29.581589958159,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,5088,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,26.6108786610879,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2718,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,%,14.2154811715481,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,count,5459,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,%,28.5512552301255,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,count,1200,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,%,6.27615062761506,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,%,0.0941422594142259,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,999,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,5.22489539748954,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,count,10443,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,%,54.6182008368201,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,count,4000,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,%,20.9205020920502,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,count,19120,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,%,0.115062761506276,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,count,339,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.77301255230126,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,count,6503,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,%,34.0115062761506,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,count,2660,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,%,13.9121338912134,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,count,378,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,%,1.97698744769874,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,count,6036,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,%,31.5690376569038,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,count,3168,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,%,16.5690376569038,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,count,1526,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,%,7.98117154811716,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,count,4946,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,%,25.8682008368201,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,count,422,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,%,2.2071129707113,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,count,19107,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,%,99.9320083682008,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,count,502,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,%,2.6255230125523,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,count,605,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,%,3.16422594142259,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,count,207,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,%,1.0826359832636,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,count,1229,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,%,6.42782426778243,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,count,6789,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,%,35.5073221757322,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,count,8987,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,%,47.0031380753138,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,count,1908,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,%,9.97907949790795,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,count,19120,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Female,categorical,count,14266,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Female,categorical,%,74.6129707112971,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Male,categorical,count,4854,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Male,categorical,%,25.3870292887029,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,count,7251,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,%,37.923640167364,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,count,10026,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,%,52.4372384937238,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,count,1843,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,%,9.63912133891213,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number subjects,NA,NA,count,37497,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number records,NA,NA,count,37497,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,median,59,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,q75,68,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,median,426,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,q25,182,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,q75,798,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,median,771,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,q25,637,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,q75,1108,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,median,2020-08-26,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,q25,2019-09-25,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,q75,2021-10-03,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,median,2020-01-31,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,q25,2019-03-13,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,q75,2021-02-24,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,11073,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,29.5303624289943,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,count,20111,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,%,53.6336240232552,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antidepressants_m365_to_0,NA,binary,count,11722,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antidepressants_m365_to_0,NA,binary,%,31.2611675600715,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiepileptics_m365_to_0,NA,binary,count,7935,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiepileptics_m365_to_0,NA,binary,%,21.1616929354348,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,27591,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,73.5818865509241,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,count,37497,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antithrombotics_m365_to_0,NA,binary,count,4702,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antithrombotics_m365_to_0,NA,binary,%,12.5396698402539,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,anxiety_minf_to_0,NA,binary,count,9853,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,anxiety_minf_to_0,NA,binary,%,26.2767688081713,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,asthma_minf_to_0,NA,binary,count,5167,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,asthma_minf_to_0,NA,binary,%,13.7797690481905,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,count,7692,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,%,20.5136410912873,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,count,5778,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,%,15.4092327386191,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,count,3228,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,%,8.60868869509561,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,count,3228,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,%,8.60868869509561,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,copd_minf_to_0,NA,binary,count,3344,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,copd_minf_to_0,NA,binary,%,8.9180467770755,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,covid_minf_to_0,NA,binary,count,5265,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,covid_minf_to_0,NA,binary,%,14.0411232898632,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,dementia_minf_to_0,NA,binary,count,503,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,dementia_minf_to_0,NA,binary,%,1.34144064858522,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,count,8314,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,%,22.1724404619036,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diabetes_minf_to_0,NA,binary,count,6726,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diabetes_minf_to_0,NA,binary,%,17.9374349947996,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diuretics_m365_to_0,NA,binary,count,7115,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diuretics_m365_to_0,NA,binary,%,18.974851321439,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,count,10730,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.61562258314,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,9400,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,25.0686721604395,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,count,5301,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,%,14.1371309704776,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,gerd_minf_to_0,NA,binary,count,10047,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,gerd_minf_to_0,NA,binary,%,26.7941435314825,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,heart_failure_minf_to_0,NA,binary,count,2064,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,heart_failure_minf_to_0,NA,binary,%,5.50444035522842,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hiv_minf_to_0,NA,binary,count,50,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hiv_minf_to_0,NA,binary,%,0.133344000853402,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,2315,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.17382723951249,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypertension_minf_to_0,NA,binary,count,18706,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypertension_minf_to_0,NA,binary,%,49.8866575992746,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,count,6973,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,%,18.5961543590154,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,immunosupressants_m365_to_0,NA,binary,count,37497,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,infertility_minf_to_0,NA,binary,count,216,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,infertility_minf_to_0,NA,binary,%,0.576046083686695,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,count,1660,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.42702082833293,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,count,11496,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,%,30.6584526762141,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malaria_minf_to_0,NA,binary,%,0.0106675200682721,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,count,5778,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,%,15.4092327386191,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,count,630,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,%,1.68013441075286,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,opioids_m365_to_0,NA,binary,count,11320,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,opioids_m365_to_0,NA,binary,%,30.1890817932101,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,osteoporosis_minf_to_0,NA,binary,count,4375,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,osteoporosis_minf_to_0,NA,binary,%,11.6676000746726,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,pneumonia_minf_to_0,NA,binary,count,2700,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,pneumonia_minf_to_0,NA,binary,%,7.20057604608369,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psycholeptics_m365_to_0,NA,binary,count,10279,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psycholeptics_m365_to_0,NA,binary,%,27.4128596954423,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psychostimulants_m365_to_0,NA,binary,count,1058,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psychostimulants_m365_to_0,NA,binary,%,2.82155905805798,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,count,19166,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,%,51.1134224071259,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,stroke_minf_to_0,NA,binary,count,831,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,stroke_minf_to_0,NA,binary,%,2.21617729418353,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,count,1128,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,%,3.00824065925274,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,0 to 19,categorical,count,1279,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,0 to 19,categorical,%,3.41093954183001,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,20 to 39,categorical,count,4423,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,20 to 39,categorical,%,11.7956103154919,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,40 to 59,categorical,count,13796,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,40 to 59,categorical,%,36.7922767154706,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,60 to 79,categorical,count,15081,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,60 to 79,categorical,%,40.219217537403,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,80 to 150,categorical,count,2918,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,80 to 150,categorical,%,7.78195588980452,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,covid,categorical,count,70,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,covid,categorical,%,0.186681601194762,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,malaria,categorical,%,0.00266688001706803,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,multiple,categorical,count,59,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,multiple,categorical,%,0.157345921007014,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,none,categorical,count,18247,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,none,categorical,%,48.6625596714404,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,rheumatoid_arthritis,categorical,count,19120,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,rheumatoid_arthritis,categorical,%,50.9907459263408,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Female,categorical,count,25891,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Female,categorical,%,69.0481905219084,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Male,categorical,count,11606,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Male,categorical,%,30.9518094780916,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,after_fda_retraction,categorical,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,after_fda_retraction,categorical,%,40.5525775395365,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,before_pandemic,categorical,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,before_pandemic,categorical,%,50.057337920367,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,during_hcq_use_for_covid,categorical,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,during_hcq_use_for_covid,categorical,%,9.39008454009654,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number subjects,NA,NA,count,22836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number records,NA,NA,count,22836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,median,57,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,q25,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,q75,66,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,median,244,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,q25,114,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,q75,427,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,median,1140,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,q25,602,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,q75,1509,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,median,2021-10-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q25,2021-03-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q75,2022-03-11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,median,2021-05-28,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q25,2020-12-16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q75,2021-10-27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,6171,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,27.0231213872832,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,count,14480,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,%,63.4086530040287,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,count,7933,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,%,34.7390085829392,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,count,5131,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,%,22.468908740585,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,15841,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,69.3685409003328,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,count,3513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,%,15.3836048344719,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,count,2633,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,%,11.5300402872657,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,count,7492,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,%,32.8078472587143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,count,3516,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,%,15.3967419863374,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,count,4618,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,%,20.2224557715887,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,count,3540,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,%,15.5018392012612,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,count,2309,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,%,10.1112278857944,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,count,2309,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,%,10.1112278857944,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,count,2025,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,%,8.86757750919601,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,count,7942,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,%,34.7784200385356,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,count,308,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,%,1.34874759152216,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,count,5670,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,%,24.8292170257488,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,count,3597,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,%,15.7514450867052,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,count,4287,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,%,18.7729900157646,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,count,6446,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.2273603082852,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,7107,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,31.1219127693116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2985,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.0714661061482,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,count,7014,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,%,30.7146610614819,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,count,1282,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,%,5.61394289717989,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,%,0.113855316167455,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,1652,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.23419162725521,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,count,10858,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,%,47.5477316517779,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,count,4875,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,%,21.3478717813978,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,count,4240,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,%,18.5671746365388,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,count,135,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,%,0.5911718339464,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,count,371,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.62462778069714,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,count,6669,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,%,29.2038885969522,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,%,0.0218952531091259,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,count,3060,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,%,13.3998949027851,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,count,392,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,%,1.71658784375547,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,count,5832,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,%,25.5386232264845,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,count,2175,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,%,9.52443510246978,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,count,1903,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,%,8.33333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,count,6733,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,%,29.484147836749,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,count,1051,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,%,4.60238220353827,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,count,6503,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,%,28.4769661937292,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,count,562,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,%,2.46102644946576,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,count,685,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,%,2.99964967595025,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,count,340,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,%,1.48887721142056,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,count,3390,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,%,14.8449816079874,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,count,9294,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,%,40.6988964792433,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,count,8438,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,%,36.9504291469609,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,count,1374,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,%,6.01681555438781,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,covid,categorical,count,2072,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,covid,categorical,%,9.07339288842179,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,malaria,categorical,%,0.0175162024873008,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,multiple,categorical,count,104,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,multiple,categorical,%,0.45542126466982,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,none,categorical,count,14257,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,none,categorical,%,62.4321247153617,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,count,6399,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,%,28.0215449290594,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Female,categorical,count,16471,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Female,categorical,%,72.1273427920827,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Male,categorical,count,6365,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Male,categorical,%,27.8726572079173,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,count,22836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number subjects,NA,NA,count,17245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number records,NA,NA,count,17245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,median,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,q25,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,q75,65,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,median,749,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,q25,279,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,q75,1084,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,median,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,q75,866,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,median,2019-10-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,q25,2019-05-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,q75,2020-04-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,median,2019-03-07,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,q25,2019-01-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,q75,2019-08-13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,4965,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,28.7909538996811,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,count,10587,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,%,61.3917077413743,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,count,6008,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,%,34.8390837924036,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,count,4444,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,%,25.7697883444477,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,12625,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,73.2096259785445,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,count,3953,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,%,22.9225862568861,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,count,2124,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,%,12.3166135111627,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,count,4763,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,%,27.6195998840244,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,count,2740,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,%,15.8886633806901,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,count,3677,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,%,21.3221223543056,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,count,2958,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,%,17.1527979124384,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,count,1876,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,%,10.8785155117425,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,count,1876,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,%,10.8785155117425,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,count,1367,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,%,7.92693534357785,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,count,1102,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,%,6.39025804581038,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,count,197,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,%,1.14236010437808,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,count,4012,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,%,23.2647144099739,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,count,2626,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,%,15.2276022035373,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,count,3442,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,%,19.9594085242099,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5323,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,%,30.8669179472311,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,5117,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,29.6723688025515,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2113,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,%,12.2528269063497,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,count,5006,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,%,29.0287039721658,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,count,947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,%,5.4914467961728,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,%,0.139170774137431,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,1523,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,8.83154537547115,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,count,8294,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,%,48.0951000289939,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,count,3818,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,%,22.139750652363,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,count,5107,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,%,29.6143809799942,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,count,113,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,%,0.655262394897072,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,count,282,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.63525659611482,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,count,4766,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,%,27.6369962307915,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,%,0.0173963467671789,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,count,1965,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,%,11.3946071325022,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,count,226,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,%,1.31052478979414,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,count,5610,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,%,32.5311684546245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,count,1962,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,%,11.377210785735,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,count,1260,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,%,7.30646564221513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,count,5012,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,%,29.0634966657002,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,count,666,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,%,3.86198898231371,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,count,6963,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,%,40.3769208466222,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,count,365,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,%,2.1165555233401,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,count,553,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,%,3.20672658741664,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,0 to 19,categorical,count,238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,0 to 19,categorical,%,1.38011017686286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,20 to 39,categorical,count,2531,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,20 to 39,categorical,%,14.6767178892433,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,40 to 59,categorical,count,7332,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,40 to 59,categorical,%,42.5166714989852,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,60 to 79,categorical,count,6141,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,60 to 79,categorical,%,35.6103218324152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,80 to 150,categorical,count,1003,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,80 to 150,categorical,%,5.81617860249348,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,malaria,categorical,%,0.0115975645114526,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,multiple,categorical,%,0.0057987822557263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,none,categorical,count,10270,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,none,categorical,%,59.5534937663091,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,count,6972,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,%,40.4291098869237,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Female,categorical,count,14130,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Female,categorical,%,81.9367932734126,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Male,categorical,count,3115,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Male,categorical,%,18.0632067265874,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,before_pandemic,categorical,count,17245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,before_pandemic,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number subjects,NA,NA,count,9565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number records,NA,NA,count,9565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,median,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q25,44,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q75,65,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,median,717,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q25,287,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q75,742,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,median,1170,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q25,704,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q75,1176,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,median,2020-04-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q25,2020-04-03,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q75,2020-06-16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,median,2020-03-20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q25,2020-03-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q75,2020-04-03,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,2233,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,23.3455305802405,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,count,6655,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,%,69.5765812859383,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,count,2423,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,%,25.3319393622582,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,count,1602,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,%,16.7485624673288,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,5035,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,52.639832723471,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,count,1018,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,%,10.64296915839,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,count,892,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,%,9.32566649242028,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,count,2263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,%,23.659174072138,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,count,1258,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,%,13.1521170935703,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,count,1609,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,%,16.8217459487716,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,count,1270,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,%,13.2775744903293,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,count,755,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,%,7.89336121275484,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,count,755,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,%,7.89336121275484,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,count,541,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,%,5.65603763721903,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,count,1230,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,%,12.8593831677993,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,count,159,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,%,1.66231050705698,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,count,1649,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,%,17.2399372713016,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,count,1252,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,%,13.0893883951908,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,count,1420,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,%,14.845791949817,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,2039,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,21.3173026659697,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,2571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,26.8792472556194,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,1127,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,11.7825405122844,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,count,2269,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,%,23.7219027705175,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,count,408,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,%,4.26555148980659,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,%,0.125457396759017,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,679,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.09879769994773,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,count,3709,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,%,38.7767903815996,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,count,1696,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,%,17.7313120752744,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,count,1255,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,%,13.1207527443806,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,count,51,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,%,0.533193936225823,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,145,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.51594354417146,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,count,2511,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,%,26.2519602718244,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,%,0.0104547830632514,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,1276,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,13.3403031887088,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,count,116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,%,1.21275483533717,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,count,2136,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,%,22.3314166231051,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,count,761,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,%,7.95608991113434,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,count,798,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,%,8.34291688447465,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,count,2450,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,%,25.614218504966,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,count,423,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,%,4.42237323575536,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,1714,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,17.919498170413,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,count,191,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,%,1.99686356508102,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,count,229,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,%,2.39414532148458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,count,207,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,%,2.16414009409305,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,count,1517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,%,15.8599059069524,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,count,4068,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,%,42.5300575013068,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,count,3213,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,%,33.5912179822269,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,count,560,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,%,5.85467851542081,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,count,381,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,%,3.9832723470988,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,malaria,categorical,%,0.0104547830632514,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,%,0.115002613695766,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,none,categorical,count,7468,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,none,categorical,%,78.0763199163617,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,count,1704,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,%,17.8149503397804,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,count,6063,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,%,63.3873497124935,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,count,3502,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,%,36.6126502875065,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,count,9565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number subjects,NA,NA,count,2453,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number records,NA,NA,count,2453,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,median,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,q25,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,q75,63,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,median,218,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,q25,94,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,q75,457,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,median,1202,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,q25,737,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,q75,1487,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,median,2021-04-22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,q25,2020-10-16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,q75,2021-11-03,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,median,2021-03-29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,q25,2020-10-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,q75,2021-10-17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,670,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,27.3134936812067,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,count,2116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,%,86.2617203424378,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antidepressants_m365_to_0,NA,binary,count,607,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antidepressants_m365_to_0,NA,binary,%,24.7452099470037,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiepileptics_m365_to_0,NA,binary,count,350,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiepileptics_m365_to_0,NA,binary,%,14.2682429677945,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,1755,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,71.5450468813698,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,count,79,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,%,3.22054626987362,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antithrombotics_m365_to_0,NA,binary,count,255,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antithrombotics_m365_to_0,NA,binary,%,10.3954341622503,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,anxiety_minf_to_0,NA,binary,count,691,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,anxiety_minf_to_0,NA,binary,%,28.1695882592744,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,asthma_minf_to_0,NA,binary,count,350,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,asthma_minf_to_0,NA,binary,%,14.2682429677945,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,count,440,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,%,17.9372197309417,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,count,332,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,%,13.5344476151651,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,count,193,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,%,7.8679168365267,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,count,193,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,%,7.8679168365267,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,copd_minf_to_0,NA,binary,count,165,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,copd_minf_to_0,NA,binary,%,6.72645739910314,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,covid_minf_to_0,NA,binary,count,2453,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,covid_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,dementia_minf_to_0,NA,binary,count,52,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,dementia_minf_to_0,NA,binary,%,2.11985324092947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,depressive_disorder_minf_to_0,NA,binary,count,448,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,depressive_disorder_minf_to_0,NA,binary,%,18.263350998777,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diabetes_minf_to_0,NA,binary,count,486,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diabetes_minf_to_0,NA,binary,%,19.8124745209947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diuretics_m365_to_0,NA,binary,count,354,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diuretics_m365_to_0,NA,binary,%,14.4313086017122,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,578,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,23.5629841011007,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,1090,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,44.4353852425601,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,408,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,16.6326946596005,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,gerd_minf_to_0,NA,binary,count,672,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,gerd_minf_to_0,NA,binary,%,27.3950264981655,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,heart_failure_minf_to_0,NA,binary,count,122,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,heart_failure_minf_to_0,NA,binary,%,4.97350183448838,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hiv_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hiv_minf_to_0,NA,binary,%,0.203832042397065,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,150,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.11496127191194,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypertension_minf_to_0,NA,binary,count,1170,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypertension_minf_to_0,NA,binary,%,47.6966979209132,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypothyroidism_minf_to_0,NA,binary,count,381,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypothyroidism_minf_to_0,NA,binary,%,15.5320016306563,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,immunosupressants_m365_to_0,NA,binary,count,59,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,immunosupressants_m365_to_0,NA,binary,%,2.40521810028536,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,infertility_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,infertility_minf_to_0,NA,binary,%,0.326131267835304,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.10069302894415,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,count,731,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,%,29.8002445984509,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,265,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,10.8030982470444,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,count,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,%,1.83448838157358,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,opioids_m365_to_0,NA,binary,count,544,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,opioids_m365_to_0,NA,binary,%,22.1769262128007,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,osteoporosis_minf_to_0,NA,binary,count,97,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,osteoporosis_minf_to_0,NA,binary,%,3.95434162250306,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,pneumonia_minf_to_0,NA,binary,count,533,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,pneumonia_minf_to_0,NA,binary,%,21.7284957195271,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psycholeptics_m365_to_0,NA,binary,count,575,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psycholeptics_m365_to_0,NA,binary,%,23.4406848756625,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psychostimulants_m365_to_0,NA,binary,count,92,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psychostimulants_m365_to_0,NA,binary,%,3.75050958010599,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,stroke_minf_to_0,NA,binary,count,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,stroke_minf_to_0,NA,binary,%,2.28291887484713,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,count,46,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,%,1.875254790053,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,0 to 19,categorical,count,52,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,0 to 19,categorical,%,2.11985324092947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,20 to 39,categorical,count,442,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,20 to 39,categorical,%,18.0187525479005,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,40 to 59,categorical,count,1116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,40 to 59,categorical,%,45.4953118630249,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,60 to 79,categorical,count,702,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,60 to 79,categorical,%,28.6180187525479,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,80 to 150,categorical,count,141,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,80 to 150,categorical,%,5.74806359559723,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,covid,categorical,count,2453,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Female,categorical,count,1269,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Female,categorical,%,51.7325723603751,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Male,categorical,count,1184,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Male,categorical,%,48.2674276396249,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,after_fda_retraction,categorical,count,2072,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,after_fda_retraction,categorical,%,84.4679983693437,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,during_hcq_use_for_covid,categorical,count,381,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,during_hcq_use_for_covid,categorical,%,15.5320016306563,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number subjects,NA,NA,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number records,NA,NA,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age,NA,numeric,median,55,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age,NA,numeric,q25,34,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age,NA,numeric,q75,65.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,future_observation,NA,numeric,median,526,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,future_observation,NA,numeric,q25,285.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,future_observation,NA,numeric,q75,792,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,prior_history,NA,numeric,median,967,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,prior_history,NA,numeric,q25,782.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,prior_history,NA,numeric,q75,1275.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_end_date,NA,date,median,2020-12-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_end_date,NA,date,q25,2020-08-30,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_end_date,NA,date,q75,2022-03-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_start_date,NA,date,median,2020-10-21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_start_date,NA,date,q25,2020-01-29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_start_date,NA,date,q75,2021-06-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antibacterials_systemic_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antibacterials_systemic_m365_to_0,NA,binary,%,85.7142857142857,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antidepressants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antidepressants_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antiepileptics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antiepileptics_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,71.4285714285714,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antineoplastic_agents_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antineoplastic_agents_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antithrombotics_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antithrombotics_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,anxiety_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,anxiety_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,asthma_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,asthma_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,beta_blocking_agents_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,beta_blocking_agents_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,calicum_channel_blockers_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,calicum_channel_blockers_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,chronic_kidney_disease_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,chronic_liver_disease_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,copd_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,copd_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,covid_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,covid_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,depressive_disorder_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,depressive_disorder_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,diabetes_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,diabetes_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,diuretics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,diuretics_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_acid_related_disorder_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_used_in_diabetes_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_used_in_diabetes_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,gerd_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,gerd_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,heart_failure_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,heart_failure_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hypertension_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hypertension_minf_to_0,NA,binary,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hypothyroidism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hypothyroidism_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,immunosupressants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,immunosupressants_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,inflammatory_bowel_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,inflammatory_bowel_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,lipid_modifying_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,lipid_modifying_agents_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,malaria_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,malaria_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,malignant_neoplastic_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,malignant_neoplastic_disease_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,opioids_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,opioids_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,osteoporosis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,osteoporosis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,pneumonia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,pneumonia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,psycholeptics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,psycholeptics_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,stroke_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,stroke_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,venous_thromboembolism_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,venous_thromboembolism_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,0 to 19,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,20 to 39,categorical,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,40 to 59,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,40 to 59,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,60 to 79,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,60 to 79,categorical,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,80 to 150,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,80 to 150,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,malaria,categorical,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,malaria,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,sex,Female,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,sex,Female,categorical,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,sex,Male,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,sex,Male,categorical,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,after_fda_retraction,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,after_fda_retraction,categorical,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,before_pandemic,categorical,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,during_hcq_use_for_covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,during_hcq_use_for_covid,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number subjects,NA,NA,count,116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number records,NA,NA,count,116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,median,57,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,q25,48,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,q75,69,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,median,177.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,q25,60.75,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,q75,423,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,median,1198.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,q25,720,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,q75,1526.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,median,2021-11-13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,q25,2021-01-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,q75,2022-03-30,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,median,2021-08-25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,q25,2020-12-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,q75,2022-01-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,39,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,33.6206896551724,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,count,102,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,%,87.9310344827586,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antidepressants_m365_to_0,NA,binary,count,51,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antidepressants_m365_to_0,NA,binary,%,43.9655172413793,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiepileptics_m365_to_0,NA,binary,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiepileptics_m365_to_0,NA,binary,%,35.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,96,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,82.7586206896552,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,count,38,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,%,32.7586206896552,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antithrombotics_m365_to_0,NA,binary,count,31,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antithrombotics_m365_to_0,NA,binary,%,26.7241379310345,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,anxiety_minf_to_0,NA,binary,count,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,anxiety_minf_to_0,NA,binary,%,38.7931034482759,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,asthma_minf_to_0,NA,binary,count,32,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,asthma_minf_to_0,NA,binary,%,27.5862068965517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,count,32,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,%,27.5862068965517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,count,31,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,%,26.7241379310345,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,count,21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,%,18.1034482758621,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,count,21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,%,18.1034482758621,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,copd_minf_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,copd_minf_to_0,NA,binary,%,25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,covid_minf_to_0,NA,binary,count,115,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,covid_minf_to_0,NA,binary,%,99.1379310344828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,dementia_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,dementia_minf_to_0,NA,binary,%,5.17241379310345,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,count,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,%,38.7931034482759,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diabetes_minf_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diabetes_minf_to_0,NA,binary,%,23.2758620689655,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diuretics_m365_to_0,NA,binary,count,37,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diuretics_m365_to_0,NA,binary,%,31.8965517241379,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,count,53,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,%,45.6896551724138,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,59,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,50.8620689655172,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.7931034482759,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,gerd_minf_to_0,NA,binary,count,63,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,gerd_minf_to_0,NA,binary,%,54.3103448275862,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,heart_failure_minf_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,heart_failure_minf_to_0,NA,binary,%,16.3793103448276,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.03448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypertension_minf_to_0,NA,binary,count,77,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypertension_minf_to_0,NA,binary,%,66.3793103448276,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,%,25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,immunosupressants_m365_to_0,NA,binary,count,47,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,immunosupressants_m365_to_0,NA,binary,%,40.5172413793103,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,infertility_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,infertility_minf_to_0,NA,binary,%,0.862068965517241,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.31034482758621,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,count,40,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,%,34.4827586206897,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malaria_minf_to_0,NA,binary,%,1.72413793103448,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,%,12.9310344827586,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,%,4.31034482758621,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,opioids_m365_to_0,NA,binary,count,43,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,opioids_m365_to_0,NA,binary,%,37.0689655172414,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,osteoporosis_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,osteoporosis_minf_to_0,NA,binary,%,12.9310344827586,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,pneumonia_minf_to_0,NA,binary,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,pneumonia_minf_to_0,NA,binary,%,35.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psycholeptics_m365_to_0,NA,binary,count,48,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psycholeptics_m365_to_0,NA,binary,%,41.3793103448276,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psychostimulants_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psychostimulants_m365_to_0,NA,binary,%,6.89655172413793,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,count,116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,stroke_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,stroke_minf_to_0,NA,binary,%,4.31034482758621,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,%,11.2068965517241,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,20 to 39,categorical,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,20 to 39,categorical,%,8.62068965517241,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,40 to 59,categorical,count,53,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,40 to 59,categorical,%,45.6896551724138,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,60 to 79,categorical,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,60 to 79,categorical,%,35.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,80 to 150,categorical,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,80 to 150,categorical,%,10.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,multiple,categorical,count,116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,multiple,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Female,categorical,count,88,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Female,categorical,%,75.8620689655172,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Male,categorical,count,28,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Male,categorical,%,24.1379310344828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,after_fda_retraction,categorical,count,104,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,after_fda_retraction,categorical,%,89.6551724137931,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,before_pandemic,categorical,%,0.862068965517241,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,during_hcq_use_for_covid,categorical,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,during_hcq_use_for_covid,categorical,%,9.48275862068965,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number subjects,NA,NA,count,31995,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number records,NA,NA,count,31995,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,median,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,q25,43,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,q75,64,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,median,399,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,q25,166,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,q75,738,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,median,888.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,q25,662,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,q75,1187,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,median,2020-08-16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,q25,2020-03-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,q75,2021-09-25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,median,2020-03-30,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,q25,2019-09-06,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,q75,2021-04-16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,7729,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,24.1568995155493,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,count,20793,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,%,64.9882794186592,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antidepressants_m365_to_0,NA,binary,count,10055,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antidepressants_m365_to_0,NA,binary,%,31.4267854352243,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiepileptics_m365_to_0,NA,binary,count,6648,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiepileptics_m365_to_0,NA,binary,%,20.7782466010314,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,19984,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,62.4597593373965,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,count,2829,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,%,8.84200656352555,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antithrombotics_m365_to_0,NA,binary,count,3270,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antithrombotics_m365_to_0,NA,binary,%,10.2203469292077,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,anxiety_minf_to_0,NA,binary,count,9257,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,anxiety_minf_to_0,NA,binary,%,28.9326457258947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,asthma_minf_to_0,NA,binary,count,4541,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,asthma_minf_to_0,NA,binary,%,14.1928426316612,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,count,5756,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,%,17.9903109860916,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,count,4536,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,%,14.1772151898734,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,count,2839,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,%,8.87326144710111,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,count,2839,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,%,8.87326144710111,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,copd_minf_to_0,NA,binary,count,1852,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,copd_minf_to_0,NA,binary,%,5.78840443819347,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,covid_minf_to_0,NA,binary,count,5474,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,covid_minf_to_0,NA,binary,%,17.1089232692608,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,dementia_minf_to_0,NA,binary,count,320,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,dementia_minf_to_0,NA,binary,%,1.00015627441788,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,depressive_disorder_minf_to_0,NA,binary,count,6852,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,depressive_disorder_minf_to_0,NA,binary,%,21.4158462259728,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diabetes_minf_to_0,NA,binary,count,4144,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diabetes_minf_to_0,NA,binary,%,12.9520237537115,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diuretics_m365_to_0,NA,binary,count,5253,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diuretics_m365_to_0,NA,binary,%,16.418190342241,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,count,8119,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,%,25.3758399749961,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,8973,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,28.0450070323488,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,count,3698,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,%,11.5580559462416,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,gerd_minf_to_0,NA,binary,count,8405,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,gerd_minf_to_0,NA,binary,%,26.2697296452571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,heart_failure_minf_to_0,NA,binary,count,1354,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,heart_failure_minf_to_0,NA,binary,%,4.23191123613065,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hiv_minf_to_0,NA,binary,count,43,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hiv_minf_to_0,NA,binary,%,0.134395999374902,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,2790,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,8.72011251758087,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypertension_minf_to_0,NA,binary,count,13041,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypertension_minf_to_0,NA,binary,%,40.7594936708861,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypothyroidism_minf_to_0,NA,binary,count,6442,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypothyroidism_minf_to_0,NA,binary,%,20.1343959993749,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,immunosupressants_m365_to_0,NA,binary,count,3371,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,immunosupressants_m365_to_0,NA,binary,%,10.5360212533208,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,infertility_minf_to_0,NA,binary,count,238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,infertility_minf_to_0,NA,binary,%,0.743866229098297,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,count,519,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.6221284575715,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,count,8101,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,%,25.3195811845601,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,count,3783,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,%,11.8237224566338,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,myocardial_infarction_minf_to_0,NA,binary,count,383,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,myocardial_infarction_minf_to_0,NA,binary,%,1.1970620409439,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,opioids_m365_to_0,NA,binary,count,7945,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,opioids_m365_to_0,NA,binary,%,24.8320050007814,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,osteoporosis_minf_to_0,NA,binary,count,2282,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,osteoporosis_minf_to_0,NA,binary,%,7.13236443194249,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,pneumonia_minf_to_0,NA,binary,count,1944,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,pneumonia_minf_to_0,NA,binary,%,6.07594936708861,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psycholeptics_m365_to_0,NA,binary,count,9075,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psycholeptics_m365_to_0,NA,binary,%,28.3638068448195,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psychostimulants_m365_to_0,NA,binary,count,1596,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psychostimulants_m365_to_0,NA,binary,%,4.98827941865917,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,stroke_minf_to_0,NA,binary,count,636,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,stroke_minf_to_0,NA,binary,%,1.98781059540553,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,count,863,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,%,2.69729645257071,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,0 to 19,categorical,count,675,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,0 to 19,categorical,%,2.10970464135021,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,20 to 39,categorical,count,5627,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,20 to 39,categorical,%,17.5871229879669,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,40 to 59,categorical,count,14056,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,40 to 59,categorical,%,43.9318643538053,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,60 to 79,categorical,count,10178,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,60 to 79,categorical,%,31.8112205032036,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,80 to 150,categorical,count,1459,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,80 to 150,categorical,%,4.56008751367401,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,none,categorical,count,31995,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,none,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Female,categorical,count,23203,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Female,categorical,%,72.5207063603688,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Male,categorical,count,8792,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Male,categorical,%,27.4792936396312,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,after_fda_retraction,categorical,count,14257,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,after_fda_retraction,categorical,%,44.560087513674,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,before_pandemic,categorical,count,10270,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,before_pandemic,categorical,%,32.0987654320988,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,during_hcq_use_for_covid,categorical,count,7468,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,during_hcq_use_for_covid,categorical,%,23.3411470542272,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number subjects,NA,NA,count,15075,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number records,NA,NA,count,15075,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,median,61,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,q25,51,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,q75,70,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,median,420,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q25,180,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q75,770,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,median,767,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q25,639,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q75,1144,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,median,2020-10-28,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q25,2019-11-12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q75,2021-12-21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,median,2020-03-16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q25,2019-03-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q75,2021-03-09,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,4928,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,32.6898839137645,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,count,8705,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,%,57.7446102819237,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,count,5649,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,%,37.4726368159204,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,count,4137,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,%,27.4427860696517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,11661,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,77.3532338308458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,count,5538,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,%,36.7363184079602,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,count,2093,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,%,13.8839137645108,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,count,4524,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,%,30.0099502487562,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,count,2590,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,%,17.1807628524046,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,count,3676,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,%,24.3847429519071,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,count,2867,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,%,19.0182421227197,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,count,1885,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,%,12.5041459369818,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,count,1885,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,%,12.5041459369818,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,count,1887,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,%,12.5174129353234,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,count,2230,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,%,14.7927031509121,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,count,286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,%,1.8971807628524,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,count,3986,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,%,26.441127694859,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,count,2818,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,%,18.6932006633499,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,count,3504,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,%,23.2437810945274,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5056,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,%,33.5389718076285,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,4671,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,30.9850746268657,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2103,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.9502487562189,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,count,5149,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,%,34.1558872305141,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,count,1142,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,%,7.57545605306799,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,%,0.0928689883913764,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,907,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.01658374792703,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,count,8569,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,%,56.8424543946932,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,count,3535,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,%,23.4494195688226,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,count,7124,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,%,47.257048092869,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,count,52,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,%,0.344941956882255,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,count,247,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.63847429519071,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,count,5073,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,%,33.6517412935323,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,count,2237,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,%,14.8391376451078,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,count,301,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,%,1.99668325041459,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,count,5046,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,%,33.4726368159204,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,count,2504,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,%,16.6102819237148,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,count,1443,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,%,9.57213930348259,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,count,4496,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,%,29.8242122719735,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,count,444,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,%,2.9452736318408,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,count,15064,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,%,99.9270315091211,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,count,421,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,%,2.79270315091211,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,count,545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,%,3.61525704809287,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,count,57,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,%,0.378109452736318,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,count,1357,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,%,9.0016583747927,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,count,5468,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,%,36.2719734660033,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,count,6868,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,%,45.558872305141,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,count,1325,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,%,8.7893864013267,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,count,15075,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Female,categorical,count,12100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Female,categorical,%,80.2653399668325,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Male,categorical,count,2975,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Male,categorical,%,19.7346600331675,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,count,6399,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,%,42.4477611940299,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,count,6972,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,%,46.2487562189055,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,count,1704,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,%,11.3034825870647,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number subjects,NA,NA,count,49646,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number records,NA,NA,count,49646,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,median,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,q25,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,q75,66,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,median,395,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,q25,164,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,q75,736,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,median,852,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,q25,659,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,q75,1191,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,median,2020-10-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,q25,2020-03-05,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,q75,2021-10-21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,median,2020-04-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,q25,2019-07-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,q75,2021-04-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,13369,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,26.9286548765258,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,count,31722,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,%,63.896386415824,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antidepressants_m365_to_0,NA,binary,count,16364,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antidepressants_m365_to_0,NA,binary,%,32.9613664746405,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiepileptics_m365_to_0,NA,binary,count,11177,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiepileptics_m365_to_0,NA,binary,%,22.5133948354349,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,33501,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,67.4797566772751,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,count,8484,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,%,17.0889900495508,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antithrombotics_m365_to_0,NA,binary,count,5649,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antithrombotics_m365_to_0,NA,binary,%,11.3785602062603,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,anxiety_minf_to_0,NA,binary,count,14518,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,anxiety_minf_to_0,NA,binary,%,29.2430407283568,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,asthma_minf_to_0,NA,binary,count,7514,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,asthma_minf_to_0,NA,binary,%,15.1351569109294,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,count,9904,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,%,19.9492406236152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,count,7768,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,%,15.6467791967127,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,count,4940,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,%,9.95044918019579,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,count,4940,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,%,9.95044918019579,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,copd_minf_to_0,NA,binary,count,3933,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,copd_minf_to_0,NA,binary,%,7.92208838577126,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,covid_minf_to_0,NA,binary,count,10274,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,covid_minf_to_0,NA,binary,%,20.6945171816461,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,dementia_minf_to_0,NA,binary,count,664,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,dementia_minf_to_0,NA,binary,%,1.33746928252024,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,count,11331,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,%,22.8235910244531,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diabetes_minf_to_0,NA,binary,count,7475,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diabetes_minf_to_0,NA,binary,%,15.056600733191,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diuretics_m365_to_0,NA,binary,count,9149,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diuretics_m365_to_0,NA,binary,%,18.4284735930387,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,count,13808,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,%,27.8129154413246,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,14795,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,29.8009910163961,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,count,6225,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,%,12.5387745236273,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,gerd_minf_to_0,NA,binary,count,14289,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,gerd_minf_to_0,NA,binary,%,28.7817749667647,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,heart_failure_minf_to_0,NA,binary,count,2637,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,heart_failure_minf_to_0,NA,binary,%,5.3116061716956,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hiv_minf_to_0,NA,binary,count,62,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hiv_minf_to_0,NA,binary,%,0.12488417999436,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,3854,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.76296176932683,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypertension_minf_to_0,NA,binary,count,22861,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypertension_minf_to_0,NA,binary,%,46.0480199814688,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,count,10389,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,%,20.9261571929259,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,immunosupressants_m365_to_0,NA,binary,count,10602,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,immunosupressants_m365_to_0,NA,binary,%,21.3551947790356,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,infertility_minf_to_0,NA,binary,count,299,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,infertility_minf_to_0,NA,binary,%,0.60226402932764,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,count,798,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.60738025218547,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,count,13946,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,%,28.0908834548604,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malaria_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malaria_minf_to_0,NA,binary,%,0.0181283487088587,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,count,6301,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,%,12.6918583571688,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,count,734,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,%,1.47846755025581,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,opioids_m365_to_0,NA,binary,count,13578,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,opioids_m365_to_0,NA,binary,%,27.3496354187649,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,osteoporosis_minf_to_0,NA,binary,count,4898,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,osteoporosis_minf_to_0,NA,binary,%,9.86585021955445,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,pneumonia_minf_to_0,NA,binary,count,3961,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,pneumonia_minf_to_0,NA,binary,%,7.97848769286549,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psycholeptics_m365_to_0,NA,binary,count,14195,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psycholeptics_m365_to_0,NA,binary,%,28.5924344358055,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psychostimulants_m365_to_0,NA,binary,count,2140,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psychostimulants_m365_to_0,NA,binary,%,4.31051847077307,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,count,15180,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,%,30.5764814889417,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,stroke_minf_to_0,NA,binary,count,1118,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,stroke_minf_to_0,NA,binary,%,2.25194376183378,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,count,1467,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,%,2.95492083954397,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,0 to 19,categorical,count,785,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,0 to 19,categorical,%,1.58119485960601,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,20 to 39,categorical,count,7438,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,20 to 39,categorical,%,14.9820730773879,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,40 to 59,categorical,count,20694,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,40 to 59,categorical,%,41.6831164645692,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,60 to 79,categorical,count,17792,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,60 to 79,categorical,%,35.837731136446,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,80 to 150,categorical,count,2937,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,80 to 150,categorical,%,5.9158844619909,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,covid,categorical,count,2453,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,covid,categorical,%,4.94098215364783,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,malaria,categorical,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,malaria,categorical,%,0.0140998267735568,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,multiple,categorical,count,116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,multiple,categorical,%,0.233654272247512,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,none,categorical,count,31995,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,none,categorical,%,64.4462796599928,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,rheumatoid_arthritis,categorical,count,15075,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,rheumatoid_arthritis,categorical,%,30.3649840873384,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Female,categorical,count,36664,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Female,categorical,%,73.8508641179551,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Male,categorical,count,12982,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Male,categorical,%,26.1491358820449,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,after_fda_retraction,categorical,count,22836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,after_fda_retraction,categorical,%,45.9976634572775,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,before_pandemic,categorical,count,17245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,before_pandemic,categorical,%,34.735930387141,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,during_hcq_use_for_covid,categorical,count,9565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,during_hcq_use_for_covid,categorical,%,19.2664061555815,PHARMETRICS
